Tackling Traumatic Brain Injury (TBI) in Montana Patel’s
Patel’s group studies changes in RNA molecules in dis-ease, such as TBI, ALS, and brain tumors. Recent work has identified microRNAs that may serve as potential blood-based biomarkers for developing novel diagnostic tests and therapeutics for neurological disorders. In 2016, he co-founded a Missoula-based company, FYR Diag-nostics, LLC to develop miRNA biomarker technologies.
Patel, Sarjubhai A., "Tackling Traumatic Brain Injury (TBI) in Montana Patel’s" (2018). Public Lecture Series. 136.